About: Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1997 (uk) article scientifique publié en 1997 (fr) im Juni 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1997 (ast) scientific article published on 01 June 1997 (en)
publication date	wds:Q73383185-B71D16EF-3FB2-4D24-BE21-2FAFB19685DA
publication date	1997-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73383185-B92DBF17-8D8E-4451-B24B-EFFCEE5B8D84
language of work or name	English
author name string	wds:Q73383185-04F76967-69CE-4AF3-96CD-A3E2E737A2A1 wds:Q73383185-182400A8-FC1D-4E93-A2EF-3050AAF0A2DE wds:Q73383185-18E334C8-B21D-4BC9-96B0-65CE92BF8F28 wds:Q73383185-272F2817-BFA1-4099-97EE-68925C1AAF0B wds:Q73383185-2A6E37A1-6F11-4430-8C6E-B820284F3BBA wds:Q73383185-589E6F1C-9247-4319-A6A7-D26BE898E169 wds:Q73383185-898DD475-60BF-4940-8F51-1DCF4E164365 wds:Q73383185-A37DDC2B-F417-4277-84AD-0A8C1298798D wds:Q73383185-A9017D32-1A82-454A-A04C-FC9093B61745
author name string	Bangerter M Reske SN Herrmann F Diederichs CG Kotzerke J Merkle E Guhlmann A Kolokythas O Moog F
rdfs:label	Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (nl) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging (en)
skos:prefLabel	Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (nl) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging (en)
name	Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (nl) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging (en)
title	wds:Q73383185-9385C8E7-F4E8-47ED-83D9-A8A939053661
title	Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging (en)
page(s)	wds:Q73383185-580E3BD7-E521-451F-AE23-5D9F13F7D868
page(s)	795-800
instance of	wds:Q73383185-8CEF4F23-082C-44E6-9781-09F2D8F07AB9
instance of	scholarly article
PubMed ID	wds:Q73383185-DF066E97-AADF-446B-B7E1-26547BD31019
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9169707
PubMed ID	9169707
published in	wds:Q73383185-F5D3AB45-469C-44A9-9DF4-4C611F53C7F6
published in	Radiology
issue	wds:Q73383185-5F7E10E4-CCDF-4F68-A5B6-8A9A74E5BC91
volume	wds:Q73383185-9E855F2B-F2BC-47F0-BA26-5FB2B95C73DD
issue	3
volume	203
DOI	wds:Q73383185-143347A9-D3F1-4F32-B9D2-8567D526CF51
DOI	http://dx.doi.org/10.1148/RADIOLOGY.203.3.9169707
DOI	10.1148/RADIOLOGY.203.3.9169707
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73383185
is cites work of	Initial experience with FDG-PET/CT in the evaluation of breast cancer Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease Positron emission tomography imaging in oncology Clinical imaging of cancer metastasis. 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Recent advances in the diagnosis and therapy of Richter's syndrome PET Scans in the Staging of Lymphoma: Current Status 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma 18F-FDG PET in children with lymphomas Role of PET/CT in malignant pediatric lymphoma Positron emission tomography: an advanced nuclear medicine imaging technique from research to clinical practice FDG-PET/CT in lymphoma [Importance of PET/CT in lymphoma diagnostics]. The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression MRI and PET in monitoring response in lymphoma FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy Clinical role of positron emission tomography in oncology FDG PET in the management of lymphoma: a clinical perspective 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients [18F]-FDG positron imaging in clinical management of lymphoma patients. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma. Positron emission tomography (PET) in clinical oncology. Part II Has PET become an important clinical tool in paediatric imaging? Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma. Positron emission tomography and gallium metabolic imaging in lymphoma Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma Whole-body diffusion-weighted imaging in lymphoma. Lymphoma: a clinical view Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values. [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax]. Diagnostic value of software-based image fusion of computed tomography and F18-FDG PET scans in patients with malignant lymphoma PET in lymphoma Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease Radionuclide evaluation of patients with lymphoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software